Penn Sleep Centers Newsletter

Spring 2006

Sleep in the Elderly
History of Penn Sleep Centers
Sleep in Women: A New Perspective
Finding the Cause of Residual Sleeplessness in Sleep Apnea
<< Back to Penn Sleep Centers home page

Finding the Cause of Residual Sleeplessness in Sleep Apnea

Obstructive sleep apnea (OSA) with daytime sleepiness, hypersomnolence and fatigue is present in at least 12 million adults in the United States. Two thirds of adults with OSA complain of significant sleepiness, which correlates with severity of cognitive impairment in these individuals. When treated for OSA, patients typically report marked improvement in sleepiness and fatigue. However, randomized controlled trials measuring sleepiness with the multiple sleep latency test show that many individuals with sleep apnea still have significant sleepiness despite successful treatment.

The observation of persistent sleepiness in patients despite proper CPAP pressures, full patient compliance and the exclusion of other sleep disorders, prompted Dr. Sigrid Veasey and co-workers in Penn's Center for Sleep and Respiratory Neurobiology to ask a novel clinical question: what physiological perturbance in OSA best predicts residual sleepiness?

Based on the observation that oxygen desaturation correlates best with sleepiness, rather than sleep time, apnea/hypopnea index or arousal index, Dr. Veasey decided to use a murine model to examine the effect of long-term intermittent hypoxia on sleep and sleepiness.

She found that long-term intermittent hypoxia in mice results in marked reductions in wake time persisting at least several weeks after normal oxygenation is restored. In addition, average sleep latency and duration of wakefulness are significantly shortened. This persistence in impaired wakefulness following long-term intermittent hypoxia prompted Dr. Veasey to ask whether neurons in wake-active regions might be vulnerable to lasting oxidative injury from long-term intermittent hypoxia.

Long-term intermittent hypoxia increases nitration and oxidation in many brain regions including those involved in sleep/wake control. A major source of longterm intermittent hypoxia -induced nitration appears to be inducible nitric oxide synthase (iNOS): Mice with transgenic absence of functional iNOS have less impaired wakefulness following long-term intermittent hypoxia and less nitration injury in wake active regions. In wild type mice, acute inhibition of iNOS following long-term intermittent hypoxia reduces the proinflammatory response, but oxidation injury persists. Thus, irreversible oxidative injury to wake areas occurs from the hypoxia/reoxygenation events of sleep apnea.

Hypothesizing that the major source of superoxide radicals producing oxidative injury in long-term intermittent hypoxia is NAD(P)H oxidase, Dr. Veasey studied the effects of transgenic absence of functional NADPH oxidase and pharmacological inhibition of NADPH oxidase during long-term intermittent hypoxia in mice. She found that both transgenic absence and pharmacological inhibition conferred complete resistance to impaired wakefulness, oxidation, the proinflammatory response, and nitration.

Thus, NADPH oxidase appears to be at the gateway for most long-term intermittent hypoxic injuries. This provides an enzyme to target for the prevention of residual sleepiness in sleep apnea. Future studies will further elucidate this pathway, but the findings are promising enough to begin design of clinical trials for adults with obstructive sleep apnea.


appointment icon

Need an appointment? Request one online 24 hours/day, 7 days/week or call 800-789-PENN (7366) to speak to a referral counselor.

Call 800-789-PENN
Email this Page
Find a Sleep Medicine Specialist
Other specialties...
Division of Sleep Medicine
The Sleep Center at The Children's Hospital of Philadelphia
More members...




About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2016, The Trustees of the University of Pennsylvania space